Search

file (10) (1)

OBI Information

News

HOMEWhat’s NewNews

2021.Dec.06

未分類

Corporate

OBI Pharma Announces First Cancer Patient Enrolled on OBI-999 in Phase 2 Study

2021.Apr.26

Corporate

OBI Pharma Announces First Patient Enrolled on SWOG Cancer Research Network’s OBI-3424 Phase 1/2 Study Targeting AKR1C3 in T-ALL and T-LBL

2021.Apr.11

Corporate

Poster Presentation at AACR 2021 Annual Meeting for OBI-3424, OBI-998, GLOBO H and SSEA-4

2021.Apr.06

Corporate

OBI Pharma Announces Poster Presentations at AACR 2021 Annual Meeting for OBI-3424, OBI-998, Globo H and SSEA-4

2021.Jan.06

Corporate

OBI Pharma, Inc. to Present at the 39th J.P. Morgan Healthcare Conference

2020.Nov.23

未分類

Corporate

ESMO Asia 2020 Virtual Annual Meeting for OBI-833, a Novel Anti-Globo H Targeted Therapeutic Cancer Vaccine

2020.Nov.19

未分類

Corporate

OBI Pharma Announces Presentations at ESMO Asia 2020 Virtual Annual Meeting for OBI-833, a Novel Anti-Globo H Targeted Therapeutic Cancer Vaccine

2020.Sep.14

未分類

Corporate

OBI Pharma Announces OBI-999 Presentation at 2020 World ADC Digital Meeting

2020.Jun.22

未分類

Corporate

Poster Presentations at AACR 2020 Virtual Annual Meeting II

2020.Jun.16

未分類

Corporate

OBI Pharma Announces Poster Presentations at AACR 2020 Virtual Annual Meeting II

Announcements

Latest announcements

Events

Latest events